04/26/2024
3:58 PM | Cellectar Biosciences (Filer)
| Form DEF 14A | |
04/26/2024
3:59 PM | Cellectar Biosciences (Filer)
| Form DEFA14A | |
04/25/2024
7:01 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
03/27/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
5:30 AM | Cellectar Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
7:31 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
02/14/2024
2:23 PM | Cellectar Biosciences (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G/A | |
|
02/07/2024
5:58 PM | Cellectar Biosciences (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/02/2024
5:03 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
7:00 AM | ADAR1 Partners, LP (Filed by)
Cellectar Biosciences (Subject)
| Form SC 13G | |
01/09/2024
5:02 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
7:04 PM | CARUSO JAMES V (Reporting)
Cellectar Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:04 PM | Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:05 PM | Cellectar Biosciences (Issuer)
Shustov Andrei (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:07 PM | Cellectar Biosciences (Issuer)
Kolean Chad J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:09 PM | Cellectar Biosciences (Issuer)
Lea Darrell Shane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
4:15 PM | Cellectar Biosciences (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G | |
12/05/2023
5:01 AM | Cellectar Biosciences (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
11/29/2023
3:31 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
5:30 AM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
6:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
11:15 PM | Cellectar Biosciences (Filer)
| Form EFFECT | |
10/27/2023
3:40 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2023
3:54 PM | Cellectar Biosciences (Filer)
| Form S-3/A | |
10/05/2023
3:45 PM | Cellectar Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/02/2023
3:40 PM | Cellectar Biosciences (Filer)
| Form DEF 14A | |
09/22/2023
3:40 PM | Cellectar Biosciences (Filer)
| Form PRE 14A | |
09/22/2023
3:30 PM | Cellectar Biosciences (Filer)
| Form D
Notice of Exempt Offering of Securities | |
09/08/2023
4:17 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
3:30 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:30 AM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/29/2023
3:31 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
5:03 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
5:27 PM | Cellectar Biosciences (Issuer)
Swirsky Douglas J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
5:24 PM | Cellectar Biosciences (Issuer)
Chanan-Khan Asher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
5:24 PM | Cellectar Biosciences (Issuer)
DRISCOLL FREDERICK W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
5:25 PM | Cellectar Biosciences (Issuer)
Loren Stefan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
5:26 PM | Cellectar Biosciences (Issuer)
NEIS JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
5:08 AM | Cellectar Biosciences (Filer)
| Form 8-K/A | |
06/20/2023
5:09 AM | Cellectar Biosciences (Filer)
| Form DEFA14A | |
Trump’s last act as President (Ad) You’ve probably never heard of Executive Order #13972.
Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines.  For the full story, click here. |
06/14/2023
3:25 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
3:27 PM | Cellectar Biosciences (Filer)
| Form DEFA14A | |
06/13/2023
3:30 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
7:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
7:31 AM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
